SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-267275
Filing Date
2023-10-31
Accepted
2023-10-31 16:54:55
Documents
17
Period of Report
2023-10-30
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d495430d8k.htm   iXBRL 8-K 31370
2 EX-99.1 d495430dex991.htm EX-99.1 129209
7 GRAPHIC g495430dsp001.jpg GRAPHIC 13647
8 GRAPHIC g495430dsp2.jpg GRAPHIC 6373
9 GRAPHIC g495430dsp2a.jpg GRAPHIC 9735
  Complete submission text file 0001193125-23-267275.txt   377330

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20231030.xsd EX-101.SCH 3101
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20231030_def.xml EX-101.DEF 13867
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20231030_lab.xml EX-101.LAB 22898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20231030_pre.xml EX-101.PRE 14705
11 EXTRACTED XBRL INSTANCE DOCUMENT d495430d8k_htm.xml XML 5554
Mailing Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36697 | Film No.: 231365417
SIC: 2836 Biological Products, (No Diagnostic Substances)